妊娠期COVID-19疫苗接种
尽管官方和专业机构明确推荐COVID-19疫苗接种,但孕妇疫苗犹豫仍很高。累积证据表明孕妇是COVID-19特殊风险群体,mRNA疫苗接种对孕妇安全且不增加不良妊娠结局风险,观察数据证实其高效预防重症SARS-CoV-2感染,母胎获益远大于风险。
要点
- 孕妇是COVID-19特殊风险群体,重症和不良围产结局风险增加。
- 超过18万接种者的数据显示mRNA疫苗对孕妇安全,不增加流产、早产等风险。
- 观察数据证实mRNA疫苗高效预防孕妇重症SARS-CoV-2感染,获益远大于风险。
核心结论
- mRNA疫苗接种对孕妇安全,不增加不良妊娠或新生儿结局风险。
- 观察数据证实mRNA疫苗高效预防孕妇重症SARS-CoV-2感染,母胎获益远大于潜在风险。
- 确保孕妇无限制获得COVID-19疫苗接种应成为全球各国优先事项。
研究设计与样本
- 原文为综述,汇总官方和专业机构推荐、超过18万接种者的安全性数据及多项观察性研究。
主要发现
- 孕妇是COVID-19特殊风险群体,ICU入住、ECMO需求、早产和围产期死亡风险增加。
- 超过18万接种者的数据显示mRNA疫苗对孕妇安全。
- 许多观察性研究比较接种与未接种孕妇的围产结局,未显示对妊娠或新生儿有害。
- mRNA疫苗不增加流产、早产、低出生体重、母体或新生儿ICU入住、胎儿死亡、胎儿异常或肺栓塞风险。
- 观察数据 corroborate 随机试验结果,mRNA疫苗高效预防孕妇重症SARS-CoV-2感染。
临床怎么用
- 官方和专业机构明确推荐COVID-19疫苗接种。
- 确保孕妇无限制获得COVID-19疫苗接种应成为全球各国优先事项。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite a recent endorsement from official and professional bodies unequivocally recommending COVID-19 vaccination, vaccine hesitancy among pregnant people remains high. The accumulated evidence demonstrates that pregnant people are a special risk group for COVID-19, with an increased risk of intensive care unit admission, extracorporeal membranous oxygenation requirement, preterm birth, and perinatal death. These risks are further increased with some variants of concern, and vaccination of pregnant people reduces the COVID-19-related increase in maternal or fetal morbidity. Data from more than 180,000 vaccinated persons show that immunization against COVID-19 with an mRNA vaccine is safe for pregnant people. Many observational studies comparing perinatal outcomes between vaccinated and unvaccinated pregnant people have had reassuring findings and did not demonstrate harmful effects on pregnancy or the newborn. Immunization with mRNA vaccines does not increase the risk of miscarriage, preterm delivery, low birthweight, maternal or neonatal intensive care unit admission, fetal death, fetal abnormality, or pulmonary embolism. Moreover, observational data corroborate the findings of randomized trials that mRNA vaccination is highly effective at preventing severe SARS-CoV-2 infection in pregnant people, emphasizing that the potential maternal and fetal benefits of vaccination greatly outweigh the potential risks of vaccination. Ensuring pregnant people have unrestricted access to COVID-19 vaccination should be a priority in every country worldwide.
引用
- Kalafat E, Heath P, Prasad S, et al. COVID-19 vaccination in pregnancy. Am J Obstet Gynecol. 2022. PMID: 35568189. doi:10.1016/j.ajog.2022.05.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。